Which 7-OH Brands Survive the DEA Order? An August 2026 Tracker

On July 1, 2026, the DEA signed a notice of intent to temporarily place 7-hydroxymitragynine above a specified threshold into Schedule I; the notice was published in the Federal Register on July 6 (FR Doc. 2026-13580, Docket No. DEA-1570). Under the temporary-scheduling process, the order cannot take effect sooner than 30 days after that notice — which makes August 5, 2026 the earliest possible effective date. This page is a living tracker of what the order covers, which product formats fall above the line, and how the major 7-OH brands are positioned. We will update it as brands announce reformulations, pull products, or publish new lab data.

What the DEA Order Actually Covers

The notice does not schedule kratom, and it does not schedule 7-OH in all forms. It draws two specific lines:

• Botanical material: kratom (Mitragyna speciosa) plant material containing more than 0.050% 7-OH on a dry-weight basis.
• Everything else: any article containing 7-OH in amounts greater than 0.050% (weight/weight, weight/volume, or volume/volume) or greater than 1.00 milligram of 7-OH in the article.

The temporary placement would run for two years, with a possible one-year extension, and once effective the manufacture, distribution, sale, and possession of covered products become subject to the criminal, civil, and administrative provisions of the Controlled Substances Act. For the full legal walk-through — what "temporary scheduling" means procedurally and what has to happen before anything becomes permanent — see our detailed explainer on the DEA notice.

The 1.00 mg Line: Why Every Current Tablet Is Covered

Here is the part most coverage glosses over: the 1.00 mg-per-article threshold captures essentially the entire finished-product category as it exists today. These are labeled strengths we verified on live product listings in July 2026:

Yes, our own tablets are on that list. Any brand telling you its current-strength 7-OH tablets are unaffected by the order is not reading the same Federal Register notice we are. The honest framing: if the order takes effect as written, every tablet above falls above the threshold, and what happens next depends on litigation, rulemaking comments already filed, and how quickly brands can reformulate or pivot.

Brand-by-Brand Tracker

We have published detailed, lab-data-driven reviews of the major brands in this category. As of this update, we have seen no public announcement from any of them of a sub-threshold (under 1.00 mg per unit) product line; we will link announcements here as they appear.

• Kreleaf — the category's biggest name; our full review covers its lineup and lab record.
• Feel Free — the category's best-known beverage; a different case, because its maker states the Classic tonic is whole-leaf kratom with under 0.5 mg of 7-OH per serving (see FAQ below).
• 7Tabz and 7OHMZ — tablet-first brands squarely above the 1 mg line.
• Simply 7OH and Opia — reviewed against published lab data.
• Payless Kratom and Real Botanicals — multi-brand retailers whose shelves are mostly above-threshold today.

Which Vendors Are Still Shipping?

The accurate category-level answer as of August 4, 2026: online 7-OH retailers are still accepting orders, because no scheduling order is in effect. We do not track any individual competitor’s order book, and we are not asserting that any named company has stopped selling — we have no verified basis for that claim and will not make one.

What we can state is our own logistics. Favor’d Alkz accepts orders for the 7-OH catalog until Wednesday, August 5, 3:33 PM PT, with the USPS Overnight carrier handoff at 11:30 AM PT that day. That is a shipping deadline, not a prediction about anyone else’s.

The more useful question than “who is still shipping” is what is still in scope, because two separate notices govern that — and the second one is routinely misread.

MGM-15 and pseudoindoxyl are named too — they are not a “legal 7-OH alternative”

Some products in this category are currently marketed as legal alternatives to 7-OH on the strength of containing MGM-15. That framing is inconsistent with the published record. The second Notice of Intent, DEA-1644 (FR Doc. 2026-13581), names mitragynine pseudoindoxyl, MGM-15 and MGM-16 for temporary Schedule I placement on the same timeline as concentrated 7-OH under DEA-1570.

We state this plainly because we previously sold pseudoindoxyl and MGM-15 products ourselves, and our own customers are owed the same disclosure: those two classes are named in DEA-1644 and sit under the same August 5 earliest-effective-date timeline as our 7-OH catalog. Per-lot certificates for what we shipped are archived on our lab results page.

Which product class is not named in either notice?

Mitragynine. Neither DEA-1570 nor DEA-1644 names mitragynine or kratom leaf. Our Watermelon MIT Tablets are a pressed mitragynine tablet: the PharmLabs San Diego certificate (ISO/IEC 17025 Acc. 85368, sample SD260729-018) reports 128.66 mg of mitragynine per serving, with 7-OH and MGM-15 reported as Not Detected. On the face of that certificate, the product does not fall within either scheduled class. The rest of that line is on the mitragynine tablets collection page.

To be precise about what we are and are not saying: we are describing what the Federal Register notices contain and what the certificate of analysis reports. We are not telling you any product is legal, and we are not predicting that anything will stay that way. State law applies independently of the federal record, and the federal record can change. Adults 21+ only.

The Possible Compliance Paths

Between now and an effective date, brands realistically have five options. None of this is legal advice; it is a map of the terrain:

• Reformulate below the thresholds — products under 0.050% concentration and 1.00 mg per article sit outside the order as written. Expect a wave of micro-dose formats if the order takes effect.
• Shift to leaf-based products — kratom leaf naturally contains 7-OH well below 0.050% dry weight, which is exactly why the notice drew the line there.
• Fight the rulemaking — comments were filed before the period closed; temporary orders have been challenged before.
• Exit — some brands may leave the category. Discontinued SKUs and shortened catalogs are the observable signal; we report only what we can verify.
• Wait for clarity — the order is signed but not yet effective; nothing is prohibited today that was legal in June.

What Buyers Can Do Right Now

First, know exactly what is in the products you own — the thresholds are measured in actual milligrams, not label claims, which makes per-batch, accredited lab data more relevant than it has ever been. Every batch we sell is tested by an ISO/IEC 17025 laboratory and the certificates are archived in our lab results library. Second, understand the compliant end-state: our companion piece on which 7-OH alternatives stay legal in 2026 covers the sub-threshold and leaf-based landscape in depth. Third, check your state — several states moved before the DEA did, and state law controls regardless of the federal timeline.

Timeline

• July 1, 2026 — DEA signs the notice of intent for temporary Schedule I placement.
• July 6, 2026 — Notice published in the Federal Register; 30-day clock starts.
• August 5, 2026 — Earliest date a temporary scheduling order can take effect.
• Effective date + 2 years — Temporary placement window, extendable by one year, during which permanent scheduling would be evaluated.

Last updated August 4, 2026. Bookmark this page — the tracker table and brand list are updated as the record changes.

Frequently Asked Questions

Is 7-OH banned right now?

No. As of this update, the DEA has signed and published a notice of intent to temporarily schedule 7-OH above the specified thresholds. No order is in effect yet, and by statute none can take effect before August 5, 2026. Products that were federally lawful in June remain federally lawful today. Several states have their own restrictions that apply regardless.

Does this ban kratom?

No. Kratom leaf naturally contains 7-OH far below the 0.050% dry-weight line the notice draws. The order, as written, targets concentrated and synthesized 7-OH products above the thresholds — not the plant, and not leaf products under 0.050%.

Is Kreleaf banned? Is Feel Free discontinued?

Neither, as of this update. No brand's products are currently scheduled, because the order is not yet in effect, and we have seen no public discontinuation announcement from either company. The two brands sit in very different positions, though. Kreleaf's current-strength 7-OH tablets, like every product in our tracker table, fall above the 1.00 mg-per-article threshold as written. Feel Free does not obviously share that exposure: Botanic Tonics states its flagship Classic tonic uses whole-leaf kratom with less than 0.5 mg of 7-OH per serving — which, as labeled, would place it below both thresholds. We have not independently verified that figure, and we will update the tracker when either brand announces a reformulation, a pull, or litigation.

What happens on August 5, 2026?

August 5 is the earliest date a temporary scheduling order could take effect — 30 days after Federal Register publication. The DEA is not required to act on that exact date, and comment-period filings or litigation could change the timeline. Until an order is published with an effective date, the only honest answer is: watch the Federal Register, not social media.

What should I look for in a brand between now and then?

Per-batch, accredited lab data. The thresholds are defined in actual milligrams and actual concentration, so a brand that publishes lot-matched ISO/IEC 17025 certificates can tell you precisely where each product stands — and one that cannot, cannot.

This article is provided for informational and educational purposes only. It is not medical, legal, or financial advice, and nothing here should be read as a claim about the effects of any product. These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

For adults 21+ only. Keep all 7-OH products out of reach of children and pets. Check your state and local laws before purchasing.